Pilot Study of RNS60 in Allergen-induced Bronchconstriction

Trial Profile

Pilot Study of RNS60 in Allergen-induced Bronchconstriction

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs RNS 60 (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Sponsors Revalesio
  • Most Recent Events

    • 03 Oct 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jun 2016.
    • 03 Oct 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 30 Oct 2015 Planned End Date changed from 1 Jan 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top